Navigation Links
NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate Directed Against the Fusion (F) Protein
Date:2/27/2009

Preclinical Study Shows the Investigational RSV-F Virus-like Particle Vaccine Induced Neutralizing Antibodies and Protected Mice upon Challenge

ROCKVILLE, Md., Feb. 27 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced results from a preclinical study of a Respiratory Syncytial Virus ("RSV") vaccine candidate directed against the viral fusion (F) protein. The virus utilizes the F protein to fuse with cells in the respiratory tract and cause illness. Novavax's RSV-F VLPs were made using a proprietary matrix (i.e., "core") protein decorated with the human RSV F protein. The VLPs mimic the three-dimensional structure of RSV but cannot replicate and cause disease because they contain no genetic material.

In this study, mice were vaccinated with two injections of RSV-F VLPs (10 microgram dose; no adjuvant), RSV-F VLPs with different adjuvants, inactivated RSV, live RSV, or a placebo. Neutralizing antibody responses against RSV, which are important for preventing infection and lower respiratory illness, were highest in the "VLP plus adjuvant" group; responses with VLPs alone were higher than responses observed with either live or inactivated RSV immunization. The VLPs induced strong cell mediated immune responses with activation of CD8+ cytotoxic T-lymphocytes against the F protein, which are important for protection because they kill cells infected with RSV. The RSV-F VLP vaccine candidate also protected against RSV infection, reducing the quantity of RSV virus found in the lungs of immunized mice after a challenge with live virus.

A monoclonal antibody against F protein with annual sales of $500 million is available that protects against RSV-related hospitalizations in infants and young children at high risk of severe disease. However, several injections are required and the lifespan of th
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. Novavax Reports First Quarter 2008 Financial Results
8. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
9. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
10. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
11. Novavax to Join Russell 3000 Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 17, 2014 Using microscopic polymer light resonators ... researchers at MIT,s Quantum Photonics Laboratory have developed ... the parts-per-billion range. Optical sensors are ideal for ... signal-to-noise ratio, compact, lightweight nature, and immunity to ... had been developed before, the MIT team conceived ...
(Date:7/10/2014)... observed the fractional quantum Hall effect in bilayer graphene ... be tuned by an electric field. , The ... confined to thin sheets are exposed to large magnetic ... thousands of individual electrons behave as a single system. ... well established, many details of this collective behavior remain ...
(Date:7/10/2014)... have shelled out for crude 3-D glasses, polarized ... experience. These basic devices, used to trick the ... soon be rendered obsolete with the introduction of ... researchers. , TAU doctoral students Yuval Yifat, Michal ... holography based on nanoantennas that could be used ...
(Date:1/15/2014)... an approach akin to assembling a club sandwich ... Technology (NIST) researchers have succeeded in crafting a ... flammability of foam commonly used in upholstered furniture ... the nanotube-coated polyurethane foam was reduced 35 percent ...
Breaking Biology Technology:Swell new sensors 2Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3Layered security: Carbon nanotubes promise improved flame-resistant coating 2
... Jayne Garno, LSU associate professor of chemistry in the ... government,s highest honor for scientists and engineers in the ... Early Career Award for Scientists and Engineers, or PECASE. ... a prestigious award. LSU is a rich environment for ...
... DIEGO, Nov. 10, 2010 Anadys Pharmaceuticals, Inc. (Nasdaq: ... the Lazard 7th Annual Healthcare Conference on Wednesday, November 17, ... is being held at the St. Regis New York.  Steve ... provide an overview of Anadys and its clinical development programs. ...
... Dendreon Corporation (Nasdaq: DNDN ) today ... the post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics ... manufacturing facility. Dendreon is requesting licensure for an ... U.S. Food and Drug Administration (FDA) review for ...
Cached Biology Technology:LSU’s Jayne Garno receives early career award from President 2Anadys Pharmaceuticals to Present at the Lazard Healthcare Conference 2Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility 2
(Date:7/10/2014)... Institute for Basic Science (IBS), the main organization of ... Korea, has announced that a group of researchers, led ... technology in the field of optogenetics that can remotely ... new technology "OptoTrk" and it has succeeded with neuronal ... technology is that it requires only light to activate ...
(Date:7/10/2014)... vegetable oil found in your popcorn or soap might not ... even worse, according to an analysis in the Cell Press ... growing demand for vegetable oil has already led to the ... trouble for orangutans in particular. If guidelines are not put ... large-scale industrial plantations from Asia into Africa will be bad ...
(Date:7/10/2014)... ocean as a microbial megacity, teeming with life too ... hundreds of types of bacteria can be found. ... microbes have their own daily cyclesnot unlike the residents ... commute, work, and eat at the same times., What,s ... that need solar energy to help them photosynthesize food ...
Breaking Biology News(10 mins):New optogenetic tool for controlling neuronal signalling by blue light 2Hunger for vegetable oil means trouble for Africa's great apes 2New research finds ocean's most abundant organisms have clear daily cycles 2New research finds ocean's most abundant organisms have clear daily cycles 3
... Yale researchers describe a breakthrough in safe and effective ... molecules that silence genes the first step in development ... (STDs). The work is reported May 4 as an advance ... is a promising approach for prevention and treatment of human ...
... the cancer-causing effects of smoking tobacco, according to new ... in Thoracic Oncology (EMCTO), Lugano, Switzerland. Swiss ... to a cancer centre in St Gallen between 2000 ... when they developed the cancer, despite having smoked on ...
... MAY 3, 2009 Two scientists whose work has led ... muscular dystrophy have been chosen to receive the 2009 March ... Campbell, Ph.D. and Louis M. Kunkel, Ph.D., will share the ... the genes and proteins that cause muscular dystrophy, a disorder ...
Cached Biology News:Nanotechnology holds promise for STD drug delivery 2March of Dimes awards $250,000 prize to scientists unraveling the causes of muscular dystrophy 2
Monoclonal antibodies conjugated with rhodamine...
... p- methoxyhydrocinnamamido)-3′-deoxy-N,N-dimethyladenosine, 2HCl White ... Protein synthesis inhibitor. Inhibits translation by ... chains. Induces DNA fragmentation in thymocytes ... Purity: ≥98% by TLC. ...
Mouse monoclonal antibody to PPP2R2C - protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform...
...
Biology Products: